PUBLICATIONS
EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells
Zhou Y, Petrovic J, Zhao J, Zhang W, Bigdeli A, Zhang Z, Berger SL, Pear WS, Faryabi RB
Molecular Cell
2022
Multiomics Single-cell Analysis Of Human Pancreatic Islets Reveals Novel Cellular States In Health and Type 1 Diabetes.
Fasolino M#, Schwartz GW#, Golson ML, Wang YJ, Morgan A, Liu C, Schug J, Liu J, Wu M, Traum D, Kondo A, May CL, Goldman N, Wang W, the HPAP Consortium, Feldman M, Moore JH, Japp AS, Betts MR, Faryabi RB*, Naji A*, KH Kaestner*, Vahedi G*
Nature Metabolism
2022
TooManyPeaks Identifies Drug-resistant-specific Regulatory Elements From Single-cell Leukemic Epigenomes.
Schwartz WG, Zhou Y, Petrovic J, Pear WS, Faryabi RB
Cell Reports
2021
The Vascular Landscape Of Human Cancer
Kahn BM, Lacus A, Alur RG, Wengyn MD, Schwartz GW, Li J, Sun K, Maurer HC, Olive KP, Faryabi RB*, Stanger BZ*.
Journal of Clinical Investigation
2021
ZMYND8-regulated IRF8 Transcription Axis Is An Acute Myeloid Leukemia Dependency.
Cao Z, Budinich KA, Huang H, Ren D, Lu B, Zhang Z, Chen Q, Zhou Y, Huang YH, Alikarami F, Kingsley MC, Lenard AK, Wakabayashi A, Khandros E, Bailis W, Qi J, Carroll MP, Blobel GA, Faryabi RB, Bernt KM, Berger SL, Shi J
Molecular Cell
2021
ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells
Verma P, Zhou Y,Cao Z, Deraska PV, Deb M, Arai E, Li W, Shao Y, Puentes L, Li Y, Patankar S, Mach RH, Faryabi RB, Shi J, Greenberg RA
Nature Cell Biology
2021